Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis.
Moowan ParkHo-Shin GwakSang Hyeon LeeYoung Joo LeeJi Woong KwonSang Hoon ShinHeon YooPublished in: Brain tumor research and treatment (2020)
BEV treatment for RN from BM radiotherapy resulted in favorable radiological (60%) and clinical responses (90%). Side effects were expectable and controllable. We anticipate prospective clinical trials to verify the effect of BEV monotherapy for RN.